Premium Nahrungsergänzungsmittel | artgerecht

Collagenosis: Causes, Symptoms and Treatment

Collagenosis refers to a group of autoimmune diseases affecting the connective tissue. The immune system attacks the body's own structures, potentially involving multiple organs.

Regular tips about health Regular tips about health

Things worth knowing about "Collagenosis"

Collagenosis refers to a group of autoimmune diseases affecting the connective tissue. The immune system attacks the body's own structures, potentially involving multiple organs.

What is Collagenosis?

Collagenosis is an umbrella term for a group of autoimmune diseases that primarily affect the body's connective tissue. Connective tissue is largely composed of collagen, a structural protein found in the skin, joints, blood vessels, and internal organs. In collagenosis, the immune system mistakenly targets the body's own structures, leading to inflammation and damage in various tissues and organs.

Collagenoses belong to the broader category of rheumatic diseases and are also referred to as systemic connective tissue diseases, as they frequently affect multiple organ systems simultaneously.

Types of Collagenosis

There are several distinct forms of collagenosis. The most common include:

Systemic Lupus Erythematosus (SLE): One of the most well-known forms, affecting the skin, kidneys, joints, and cardiovascular system.
Systemic Sclerosis (Scleroderma): Characterized by hardening and thickening of the skin and internal organs.
Sjogren Syndrome: Primarily affects the salivary and lacrimal glands, causing dry mouth and dry eyes.
Polymyositis and Dermatomyositis: Inflammatory muscle diseases; dermatomyositis also involves the skin.
Mixed Connective Tissue Disease (MCTD): An overlap syndrome combining features of several collagenoses.
Antiphospholipid Syndrome: Often associated with SLE, characterized by an increased risk of blood clots.

Causes and Risk Factors

The exact causes of collagenosis are not yet fully understood. A combination of several factors is thought to contribute:

Genetic predisposition: Certain gene variants increase the susceptibility to developing these diseases.
Hormonal influences: Collagenoses occur significantly more often in women of childbearing age, suggesting a role of estrogen.
Environmental triggers: UV radiation, viral infections, and certain medications can act as triggers.
Immune dysregulation: A malfunction in the immune system leads to the production of autoantibodies that attack the body's own tissue.

Symptoms

The symptoms of collagenosis vary widely depending on the specific type and the organ systems involved. Common general symptoms include:

Persistent fatigue and general malaise
Joint and muscle pain
Skin changes (e.g., butterfly rash in SLE)
Raynaud phenomenon (circulatory disturbances in the fingers when exposed to cold)
Unexplained fever
Hair loss
Dry eyes and dry mouth (in Sjogren syndrome)
Difficulty swallowing or shortness of breath when organs are affected

Diagnosis

Diagnosing collagenosis requires a thorough medical evaluation, as symptoms can be non-specific and other conditions must be ruled out. Typical diagnostic steps include:

Blood tests: Detection of specific autoantibodies such as antinuclear antibodies (ANA), anti-dsDNA, anti-Ro/SSA, anti-La/SSB, or anti-Scl-70.
Inflammatory markers: ESR, CRP, and complete blood count to assess disease activity.
Imaging studies: X-ray, ultrasound, CT, or MRI depending on the organs involved.
Tissue biopsy: A biopsy of the skin or kidney may be necessary to confirm the diagnosis.
Specialist evaluation: Typically performed by a rheumatologist or immunologist.

Treatment

Collagenoses are generally not curable, but can be well managed with modern therapies. The goals of treatment are to suppress inflammation, prevent organ damage, and improve the quality of life for those affected.

Pharmacological Therapy

Corticosteroids (e.g., prednisone): Used to rapidly reduce inflammation.
Hydroxychloroquine: Particularly used in SLE to reduce inflammation and prevent flares.
Immunosuppressants: Medications such as methotrexate, azathioprine, or mycophenolate mofetil help to suppress the overactive immune response.
Biologics: Targeted therapies such as belimumab or rituximab are used in severe cases.

Non-Pharmacological Measures

Protection from UV radiation (especially important in SLE)
Regular medical check-ups for early detection of organ damage
Physiotherapy to maintain mobility and function
Psychosocial support and patient education

Prognosis and Disease Course

The course of collagenosis varies greatly between individuals. Many conditions follow a relapsing-remitting pattern, with periods of improvement and renewed flares. Early diagnosis and consistent treatment can significantly improve the long-term outlook. Severe organ involvement, particularly of the kidneys or lungs, can complicate the disease course.

References

European League Against Rheumatism (EULAR): Recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases, 2023.
Manger, B. et al. (eds.): Rational Diagnostics and Therapy in Rheumatology. Thieme Publishing, 2019.
Tsokos, G. C.: Systemic lupus erythematosus. New England Journal of Medicine, 365(22), 2110–2121 (2011). DOI: 10.1056/NEJMra1100359

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.